These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8588206)

  • 1. Alternative PCR method for diagnosis of mutation causing activated protein C resistant Gln506-factor V.
    Greengard JS; Xu X; Gandrille S; Griffin JH
    Thromb Res; 1995 Dec; 80(5):441-3. PubMed ID: 8588206
    [No Abstract]   [Full Text] [Related]  

  • 2. Venous thrombosis: factor V G1691A genotyping related to APC resistance as measured by 2 methods.
    Alderborn A; Siegbahn A; Wadelius C
    Eur J Haematol; 1997 Apr; 58(4):229-32. PubMed ID: 9186532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis.
    Zöller B; Dahlbäck B
    Lancet; 1994 Jun; 343(8912):1536-8. PubMed ID: 7911873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to activate protein C, the Arg506 to Gln mutation in the factor V gene, and venous thrombosis. Functional tests and DNA-based assays, pros and cons.
    Dahlbäck B
    Thromb Haemost; 1995 May; 73(5):739-42. PubMed ID: 7482395
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular detection of a common mutation in coagulation factor V causing thrombosis via hereditary resistance to activated protein C.
    Liu XY; Nelson D; Grant C; Morthland V; Goodnight SH; Press RD
    Diagn Mol Pathol; 1995 Sep; 4(3):191-7. PubMed ID: 7493138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid two-stage PCR for detecting factor V G1691A mutation.
    Beauchamp NJ; Daly ME; Cooper PC; Preston FE; Peake IR
    Lancet; 1994 Sep; 344(8923):694-5. PubMed ID: 7915391
    [No Abstract]   [Full Text] [Related]  

  • 7. Resistance to activated protein C: a major cause of inherited thrombophilia.
    Jensen R; Ens GE
    Clin Lab Sci; 1997; 10(4):219-22. PubMed ID: 10169621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of activated protein C resistance (factor V Leiden).
    Baker R; Thom J; van Bockxmeer F
    Lancet; 1994 Oct; 344(8930):1162. PubMed ID: 7934522
    [No Abstract]   [Full Text] [Related]  

  • 9. [Point mutation G-->A nucleotide 1691 factor V gene as a cause of developing thrombotic complications in a family with plasma resistance to activated protein C].
    Lew Andowski KL; Rozek M; Turowiecka Z; Markiewicz WT; Zawilska K
    Pol Arch Med Wewn; 1996 May; 95(5):464-70. PubMed ID: 8848415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemic stroke in the elderly. Role of the common factor V mutation causing resistance to activated protein C.
    Press RD; Liu XY; Beamer N; Coull BM
    Stroke; 1996 Jan; 27(1):44-8. PubMed ID: 8553401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation in blood coagulation factor V associated with resistance to activated protein C.
    Bertina RM; Koeleman BP; Koster T; Rosendaal FR; Dirven RJ; de Ronde H; van der Velden PA; Reitsma PH
    Nature; 1994 May; 369(6475):64-7. PubMed ID: 8164741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population study of the G1691A mutation (R506Q, FV Leiden) in the human factor V gene that is associated with resistance to activated protein C.
    Braun A; Müller B; Rosche AA
    Hum Genet; 1996 Feb; 97(2):263-4. PubMed ID: 8566967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel factor V null mutation detected in a thrombophilic patient with pseudo-homozygous APC resistance and in an asymptomatic unrelated subject.
    Lunghi B; Castoldi E; Mingozzi F; Bernardi F; Castaman G
    Blood; 1998 Aug; 92(4):1463-4. PubMed ID: 9694743
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: prevalence of factor V Leiden.
    Hirsch DR; Mikkola KM; Marks PW; Fox EA; Dorfman DM; Ewenstein BM; Goldhaber SZ
    Am Heart J; 1996 Jun; 131(6):1145-8. PubMed ID: 8644593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral venous thrombosis and activated protein C resistance.
    Sánchez del Rio M; Gómez-Tortosa E; Outeriño J
    J Neurol; 1996 Oct; 243(10):727-8. PubMed ID: 8923308
    [No Abstract]   [Full Text] [Related]  

  • 16. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human genetics. Bad blood by mutation.
    Majerus PW
    Nature; 1994 May; 369(6475):14-5. PubMed ID: 8164730
    [No Abstract]   [Full Text] [Related]  

  • 18. The G1691A mutation of the coagulation factor V gene (factor V Leiden) is rare in Chinese: an analysis of 618 individuals.
    Ko YL; Hsu TS; Wu SM; Ko YS; Chang CJ; Wang SM; Chen WJ; Cheng NJ; Kuo CT; Chiang CW; Lee YS
    Hum Genet; 1996 Aug; 98(2):176-7. PubMed ID: 8698336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are we ready for factor V Leiden screening?
    Dahlbäck B
    Lancet; 1996 May; 347(9012):1346-7. PubMed ID: 8637335
    [No Abstract]   [Full Text] [Related]  

  • 20. Phenotyping and genotyping of coagulation factor V Leiden.
    Engel H; Zwang L; van Vliet HH; Michiels JJ; Stibbe J; Lindemans J
    Thromb Haemost; 1996 Feb; 75(2):267-9. PubMed ID: 8815574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.